Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5512-7. doi: 10.1016/j.bmcl.2008.09.013. Epub 2008 Sep 9.

Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.

Author information

1
Organic Chemistry Synthesis Division, National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, Maharashtra 411 008, India.

Abstract

Tetrapeptides derived from glycine and beta-alanine were hooked at the C-3beta position of the modified cholic acid to realize novel linear tetrapeptide-linked cholic acid derivatives. All the synthesized compounds were tested against a wide variety of microorganisms (gram-negative bacteria, gram-positive bacteria and fungi) and their cytotoxicity was evaluated against human embryonic kidney (HEK293) and human mammary adenocarcinoma (MCF-7) cell lines. While relatively inactive by themselves, these compounds interact synergistically with antibiotics such as fluconazole and erythromycin to inhibit growth of fungi and bacteria, respectively, at 1-24 microg/mL. The synergistic effect shown by our novel compounds is due to their inherent amphiphilicity. The fractional inhibitory concentrations reported are comparable to those reported for Polymyxin B derivatives.

PMID:
18805690
DOI:
10.1016/j.bmcl.2008.09.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center